Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
38 Leser
Artikel bewerten:
(0)

China's Enteral Nutrition Preparation Market Research and Investment Forecast Evaluation 2015-2020

DUBLIN, Mar. 24, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/ccv4lk/research_and) has announced the addition of the "Research and Investment Forecast Evaluation of China's Enteral Nutrition Preparation Market from 2015 to 2020" report to their offering.

600769

Enteral nutrition preparations are the main varieties in enteral nutrition support treatment. The oral enteral nutrition emulsion and suspension include TPF, TP, TPF-T and TP-HE etc different formulas. The main manufacturers are Sino-Swed Pharmaceutical Corp, Ltd. (SSPC) and Nutricia (Wuxi), the former mainly includes such brands as: Fresubin Energy Fibre, Fresubin, Supportan and Fresubin MCT 750; while the later mainly includes Nutrison fibre, Nutrison, Peptisorb Liquid and Diason etc brands.

In China, the clinical nutrition market started in 1960s-70s. After entered into China market in 1982, China-Germany joint venture Sino-Swed Pharmaceutical is the first enterprise launching fat emulsion, amino acid and other products into market. With tens of years of development, the market is segmented increasingly, each variety increases rapidly.

In recent years, with the popularization of clinical nutrition conception in China, more and more domestic enterprises set foot in this field. According to statistics, in 2010, the market scale of enteral nutrition preparation was CNY 2.21 billion in China, by the end of 2014, it was CNY 4.11 billion and increases continually.

In overall, at present, the clinical nutrition is still in development stage in China, the home-made clinical nutrition preparations still far lag behind overseas level in respects of both quality and variety, the high-grade product market is monopolized by the imported or joint-venture products. With the constant upgrades of clinical academic concepts, from the original intravenous hyperalimentation, to equal nitrogen, equal thermal treatment, to low nitrogen, low calorie parenteral nutrition solution, to enteral nutrition and to joint nutrition treatment theory, higher requirements on convenience and safety of clinical nutrition products are put forward, especially, the emergence of infusion method of All-in-one nutrient solution makes the concept: parenteral nutrition should give the most reasonable infusion method, become common sense clinically.

Key Topics Covered:

1. Overview of China's Enteral Nutrition Preparation Product

2. Enteral Nutrition Preparation in Overseas Markets


3. Environment Analysis of Enteral Nutrition Preparation

4. Market Characteristics of Enteral Nutrition Preparation

5. Development of Enteral Nutrition Preparation in China

6. Analysis on Enteral Nutrition Preparation in China

7. of Import & Export Analysis

8 Technical Development of Enteral Nutrition Preparation in China

9. Key Manufacturers and Competition Pattern in China

10 Investment Suggestions on Enteral Nutrition Preparation in China

12 Investment Suggestions and Opinions from Industry Experts

Companies Mentioned

- Netherlands Nutricia
- Sino-Swed Pharmaceutical Corp, Ltd. (SSPC)
- Abbott Laboratories
- NOVARTIS Pharmaceutical Co.,Ltd
- Xi'an Libang Clinical Nutrition Limited Company

For more information visit http://www.researchandmarkets.com/research/ccv4lk/research_and

Media Contact:
Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.